Discover
CYCN
Cyclerion Therapeutics, Inc.
3.37
2 x 2.58
2 x 4.35
bid
ask
-
0.02
0.59%
2 @ 04:00 PM
3.32 -0.05 (1.48%)
| Ytd | 165.35% | |
| 1y | 8.71% |
3.35
day range
3.59
1.03
52 week range
8.48
| Open | 3.44 | Prev Close | 3.39 | Low | 3.35 | High | 3.59 | Mkt Cap | 14.59M |
| Vol | 27.04K | Avg Vol | 379.79K | EPS | -1.31 | P/E | N/A | Forward P/E | -2.44 |
| Beta | 1.92 | Short Ratio | 0.78 | Inst. Own | 40.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.15 | 200-d Avg | 2.18 | 1yr Est | 4.00 |
| Income Statement | |||
| Operating Expenses | 3.21M | ||
| Research and Development Expense | 730.00K | ||
| Selling, General and Administrative Expense | 2.48M | ||
| Operating Income | -3.21M | ||
| Net Income | -3.18M | ||
| Net Income Common Stock | -3.18M | ||
| Net Income Common Stock (USD) | -3.18M | ||
| Consolidated Income | -3.18M | ||
| Earnings per Basic Share | -0.76 | ||
| Earnings per Basic Share (USD) | -0.76 | ||
| Earnings per Diluted Share | -0.76 | ||
| Earning Before Interest & Taxes (EBIT) | -3.18M | ||
| Earning Before Interest & Taxes (USD) | -3.18M | ||
| Weighted Average Shares | 4.21M | ||
| Weighted Average Shares Diluted | 4.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.82M | ||
| Cash and Equivalents (USD) | 2.82M | ||
| Investments | 5.35M | ||
| Investments Non-Current | 5.35M | ||
| Current Assets | 3.09M | ||
| Property, Plant & Equipment Net | 66.00K | ||
| Total Assets | 8.51M | ||
| Current Liabilities | 1.71M | ||
| Total Liabilities | 1.71M | ||
| Accumulated Retained Earnings (Deficit) | -274.20M | ||
| Shareholders Equity | 6.79M | ||
| Shareholders Equity (USD) | 6.79M | ||
| Assets Non-Current | 5.42M | ||
| Trade and Non-Trade Payables | 457.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 825.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -417.00K | ||
| Capital Expenditure | -66.00K | ||
| Issuance (Purchase) of Equity Shares | 825.00K | ||
| Net Cash Flow from Investing | -66.00K | ||
| Net Cash Flow from Operations | -1.18M | ||
| Share Based Compensation | 58.00K | ||